AnyGen Co Ltd operates in the Medicinals and botanicals sector.
In addition to historical fundamental analyses, the complete report available to purchase compares AnyGen Co Ltd with three other
pharmaceutical manufacturers in Asia:
sales of 5.21 billion Korean Won [US$4.37 million]
of which 100%
was Biomaterials Convergence Tech&Drug Deliv),
(3.11 billion Korean Won [US$2.61 million]
Piramal Phytocare Ltd
based in India
(238.14 million Indian Rupees [US$3.36 million]
AnyGen Co Ltd reported sales of 4.11 billion Korean Won (US$3.46 million)
December of 2018.
decrease of 9.6%
versus 2017, when the company's sales were 4.55 billion Korean Won.
The sales level in 2018 was fairly close to the level five years ago: in 2013, AnyGen Co Ltd had sales
of 4.01 billion Korean Won.